On-Demand Rare Disease Registry – An Industry First
ATLANTA, Georgia (Feb. 28, 2010) (HIMSS) In honor of Worldwide Rare Disease Day 2010, RemedyMD®, Inc., the leading provider of disease registry software, today announced the world’s first on-demand registry solution exclusively for rare disease research.
Click here to read the full press release.
Chronic Disease Registry for At-Risk Populations - A Research Milestone
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide Chronic Disease Registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Osteoporosis Registry Provides Research Milestone
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide Osteoporosis Registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Abdominal Surgery Registry - A Research Milestone
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide Abdominal Surgery Registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Pediatric Diabetes Registry - A Milestone for Diabetes Research
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide Pediatric Diabetes Registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Cervical Spondylotic Myelopathy Registry - A Research Milestone
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide Cervical Spondylotic Myelopathy (CSM) Registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Human Immunology Registry - A Research Milestone
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide Human Immunology Registry for infectious disease research.
Click here to read the full press release.
Comprehensive Obesity Registry - A First For Bariatric Research
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide Comprehensive Obesity registry for bariatrics to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Remote Monitoring Technologies Registry Improves Patient Care
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide Remote Monitoring Technologies registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Type 2 Diabetes Registry – A First for Diabetes Research
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide Type 2 Diabetes registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Vision Impairment Registry for Diabetics – a First for Diabetes Research
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide vision impairment registry for diabetics. The new registry was developed to help clinicians and researchers identify which interventions are most appropriate for specific patient populations..
Click here to read the full press release.
Lower Back Pain Registry Provides Research Milestone .
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide lower back pain registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Neonatal Registry Provides Research Milestone.
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide neonatal registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Cervical Pain Registry Provides Research Milestone.
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide cervical pain registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Pediatric Asthma Registry addresses one of the Institute of Medicine’s top 100 priorities for CER.
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide pediatric Asthma registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Prostate Cancer Registry Provides Research Milestone
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide Prostate Cancer registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Pediatric Obesity Registry Provides Research Milestone
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide pediatric obesity registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
Gastroesophogeal Reflux Registry Provides Research Milestone
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide Gastroesophogeal Reflux Disease (GERD) registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Click here to read the full press release.
New Disease Registries Support Comparative Effectiveness Research Priorities
RemedyMD (www.RemedyMD.com), the leading provider of specialty applications for comparative effectiveness research, announced its intent to deliver 100 highly specialized patient, disease, and clinical registries in the next 90 days.
Click here to read the full press release.
The Children’s Hospital of Denver Collaborates with RemedyMD on its Interstitial Lung Disease Research Initiative
RemedyMD, a leading provider of clinical and research solutions, and The Children’s Hospital of Denver today announced an agreement to implement RemedyMD’s OutcomeTrack™ - a Disease Registry and outcomes tracking solution. OutcomeTrack will be used to accelerate the diagnosis and treatment of pediatric diffuse lung disease, through The Children’s Interstitial Lung Disease Research Network (ChILDRN).
Click here to read the full press release.
RemedyMD Selected by CMS as PQRI Reporting Provider
RemedyMD Inc., a leading provider of clinical and research solutions to the healthcare industry, today announced that the Centers for Medicare and Medicaid Services (CMS) have formally approved RemedyMD’s OutcomeTrack™ as a participating disease registry reporting solution for the Physician Quality Reporting Initiative (PQRI).
Click here to read the full press release.
The Children’s Hospital of Denver Collaborates with RemedyMD on its Pediatric Pulmonary Hypertension Research Initiative
RemedyMD, a leading provider of clinical and translational research solutions, and The Children’s Hospital of Denver, today announced an agreement to implement RemedyMD’s OutcomeTrack™ - a component of the Investigate™ solution, a next generation clinical and translational research platform and disease registry.
Click here to read the full press release.
The BloodCenter of Wisconsin Collaborates with RemedyMD on its Translational Research Initiative
RemedyMD and BloodCenter of Wisconsin today
announced an agreement to implement RemedyMD’s Investigate™ - a next generation clinical and translational research platform - to accelerate treatment and research of blood diseases.
Click here to read the full press release.
For Archived Press Releases, Click Here.